Genetic polymorphisms of the renin-angiotensin system;POLYMORPHISMES GENETIQUES DU SYSTEME RENINE-ANGIOTENSINE

Therapie

Volumn 53, Issue 3, 1998, Pages 271-277

  Jeunemaitre, X ^a,b  

^a HÔPITAL BROUSSAIS   (France)

^b INSERM   (France)

Author keywords

Coronary heart disease; Genes; Hypertension; Left ventricular hypertrophy; Polymorphism

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ANGIOTENSIN II;

CHROMOSOMAL LOCALIZATION; ESSENTIAL HYPERTENSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ANIMAL; CHROMOSOME 1; GENETICS; METABOLISM; RAT;

ANGIOTENSIN II; ANIMALS; CHROMOSOMES, HUMAN, PAIR 1; HUMANS; LINKAGE DISEQUILIBRIUM; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RATS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032061701     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Tewksbury DA. Angiotensinogen: biochemistry and molecular biology. In: Laragh JJ, Brenner BM, eds, Hypertension, Pathophysiology, Diagnosis and Management. New York: Raven Press, 1990; 1: 1197-1216.
2. Gardes J, Bouhnik J, Clauser E et al. Role of angiotensinogen in blood pressure homeostasis. Hypertension 1982; 4: 185-189.
3. Ménard J, El-Amrani AK, Savoie F, Bouhnik J. Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension 1991; 18: 705-706.
4. Kimura S, Mullins JJ, Bunneman B et al. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 1992; 11: 821-827.
5. Okhubo H, Kawakami H, Kakehi Y et al. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci 1990; 87: 5153-5157.
6. Fukamizu A, Sugimura K, Takimoto E et al. Chimeric renin angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 1993; 268: 11617-11621.
7. Kim HS, Krege JH, Kluckman KD et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995; 92: 2735-2739.
8. Nimura F, Labosky PA, Kakuchi J et al. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 1995; 96: 2947-2954.
9. Kew MC, Leckie BJ, Greef MC. Arterial hypertension as a paraneoplastic phenomenon in hepatocellular carcinoma. Arch Intern Med 1989; 149: 2111-2113.
10. Ueno N, Yoshida N, Hirose S et al. Angiotensinogen-producing hepato-cellular carcinoma. Hypertension 1984; 6: 931-933.
11. Laragh JH, Sealey JE, Ledingham JGG, Newton MA. Oral contraceptives. Renin, aldosterone and high blood pressure. JAMA 1967; 201: 918-922.
12. Fasola AF, Martz BL, Helmer OM. Plasma renin activity during supine exercise in offspring of hypertensive patients. J Appl Phsyiol 1968; 25: 410-415.
13. Walker WG, Whelton PK, Saito H et al. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979; 1: 287-291.
14. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt HJ. The serum angiotensinogen concentration of the angiotensinogen gene in white and black children.JClin Invest 1995; 95: 948-953.
15. Jeunemaitre X, Soubrier F, Kotelevtsev W et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
16. Caulfield M, Lavender P, Farrall M et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629-1633.
17. Caulfield M, Lavender P, Newell-Price J el al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Carribeans. J Clin Invest 1995; 96: 687-692.
18. Atwood LD, Kammerer CM, Samollow PB et al. Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension 1997; 30 (part 1): 326-330.
19. Niu T, Xu X, Rogus J et al. Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998; 101: 188-194.
20. Kunz R, Kreutz R, Beige J et al. Association between the angiotensinogen 235T variant and essential hypertension in whites. A systematic review and methodological appraisal. Hypertension 1997; 30: 1331-1337.
21. Inoue I, Nakajima T, Williams CS et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786-1797.
22. Ward K, Hata A, Jeunemaitre X et al. A molecular variant associated with pre-eclampsia. Nat Genet 1993; 4: 59-61.
23. Arngrimsson R, Purandare S, Connor M et al. Angiotensinogen: a candidate gene involved in preeclampsia? Nat Genet 1993; 4: 114-115.
24. Inoue I, Rohrwasser A, Helin C et al. A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensinogen system. J Biol Chem 1995; 270: 11430-11436.
25. Gimenez-Roqueplo AP, Cohen P, Leconte I et al. The natural Y248C mutation of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein. J Biol Chem 1996; 271: 9838-9844.
26. Katsuya T, Koike G, Yee TW et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 1600-1603.
27. Marre M, Jeunemaitre X, Gallois Y et al. On behalf of the GENEDIAB group. Contribution of genetic polymorphisms of the renin angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 1997; 99: 1585-1595.
28. Pei Y, ScholeyJ, Thai K et al. Association of angiotensinogen gene T235 variant with progression of immunoglobulin A nephropathy in Caucasian patients. J Clin Invest 1997; 100: 814-820.
29. Rapp JH, Wang SM, Dene H. A genetic polymorphism in the renin gene of Dahl rats cosegregate with blood pressure. Science 1989; 243: 542-544.
30. Dubay C, Vincent M, Samani NJ et al. Genetic determinants of diastolic and pulse pressure map to different loci in Lyon hypertensive rats. Nature Genet 1993; 3: 354-357.
31. Grim CE, Luft FC, Miller JZ et al. An approach to the evaluation of genetic influences on factors that regulate arterial blood pressure in man. Hypertension 1980; 2(suppl 2): I-34-I-42.
32. Villard E, Lalau JD, Von Hooft I et al. A mutant renin gene in familial elevation of protein. J Biol Chem 1994; 269: 30307-30312.
33. Jeunemaitre X, Rigat B, Charru A et al. Sib-pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 1992; 88: 301-306.
34. Soubrier F, Hubert C, Testut P et al. Molecular biology of the angiotensin I converting enzyme, I: Biochemistry and structure of the gene. J Hypertens 1993; 11: 471-476.
35. Hilbert P, Lindpaintner K, Beckmann J et al. Chromosomal mapping of two genetic loci associated with blood pressure regulation in hereditary hypertensive rats. Nature 1991; 353: 521-526.
36. Kreutz R, Hübner N, Ganten D, Lindpaintner K. Genetic linkage of the ACE gene to plasma angiotensin-coverting enzyme activity but not to blood pressure. Circulation 1995; 92: 2381-2384.
37. Krege JH, John SWM, Langenbach et al. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995; 375: 146-148.
38. Cambien F, Soubrier F. The angiotensin-converting-enzyme: molecular biology and implication of the gene polymorphism in cardiovascular diseases. In: Laragh JH, Brenner BM, eds, Hypertension: Pathophysiology, Diagnosis and Management, 2nd ed. New York: Raven Press, 1995: 1681-1693.
39. Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion/ deletion in the angiotensin I-converting enzyme accounting for half the evidence of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
40. Villard E, Tiret L, Visvikis S et al. Identification of new polymorphisms to the angiotensin I-converting enzyme (ACE), and study of their relationship to plasma ACE levels by two-QTL segeration-linkage analysis. Am J Hum Genet 1996; 58: 1268-1278.
41. Harrap SB, Davidson R, Connor JM et al. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21: 455-460.
42. Julier C, Delepine M, Keavney B et al. Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet 1997; 6: 2077-2085.
43. Yoshida H, Kon V, Ichakawa I. Polymorphisms of the renin angiotensin system genes in progressive renal diseases. Kidney Int 1996; 50: 732-744.
44. Staessen JA, Wang JG, Ginocchio G et al. The deletion/ insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15: 1579-1592.
45. Clauser E, Curnow KM, Conchon S et al. Curr Op Endocrinol Diab 1995; 2: 404-411.
46. Bonnardeaux A, Davies E, Jeunemaitre X et al. Angiotensin II type I receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24: 63-69.
47. Davies E, Bonnardeaux A, Plouin PF et al. Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone producing adenomas. J Clin Endor Metab 1997; 82: 611-615.
48. Unger T, Chung O, Csikos T et al. Angiotensin receptors. J Hypertens 1996; 14 (suppl 5) : S95-S103.
49. Hein L, Barsh GS, Pratt RE el al. Behavioural and cardiovascular effects of disrupting the angiotensin II-type receptor gene in mice. Nature 1995; 377: 744-747.
50. Ichiki T, Labosky PA, Shiota C et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-750.